Enliven Therapeutics, Inc.ELVNNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+108.5%
5Y CAGR+66.8%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+108.5%/yr
vs +9.7%/yr prior
5Y CAGR
+66.8%/yr
Recent acceleration
Acceleration
+98.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
12.9x
Strong expansion
Streak
3 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 56664226.00 | +20.4% |
| 2024 | 47073000.00 | +32.4% |
| 2023 | 35546000.00 | +468.8% |
| 2022 | 6249000.00 | -20.0% |
| 2021 | 7815000.00 | +78.0% |
| 2020 | 4390500.00 | +1.6% |
| 2019 | 4320000.00 | 0.0% |
| 2018 | 4320000.00 | 0.0% |
| 2017 | 4320000.00 | - |